Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Clinical trial NCT03999801 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT03999801
Sponsor: AbbVie
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration Wet Macular Degeneration

Start date: 2019-05-31
Primary completion: 2028-12-01
Enrollment: 865

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.